Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe page's taxonomy/navigation now lists Melanoma as a topic and adds a Related topics section including MedlinePlus Genetics. The revision tag at the bottom updates from v3.6.2 to v3.6.3.SummaryDifference0.2%

- Check11 days agoChange DetectedThe page revision tag was updated to v3.6.2 and certain related topics were removed from the metadata, indicating a small backend or navigation tweak rather than substantive study information.SummaryDifference0.2%

- Check18 days agoChange DetectedAdded a Related topics section featuring Melanoma and MedlinePlus Genetics on the study details page to provide quick access to educational resources related to the disease.SummaryDifference0.2%

- Check25 days agoChange DetectedRecruitment status now indicates no longer looking for participants, and new help sections have been added (How to Read a Study Record, Common Questions, How to Join a Study) to assist users in navigating and understanding the study. The Intervention/Treatment heading formatting has been standardized and the page shows an updated revision note (Revision: v3.6.0).SummaryDifference0.6%

- Check34 days agoChange DetectedMelanoma is listed as a topic and MedlinePlus Genetics is shown under related topics. The page revision label has been updated from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision line updated from v3.5.3 to v3.5.4, indicating a new version of the site framework. This change does not modify the study content or related data on the page.SummaryDifference0.1%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.